Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Towards the generation of B-cell receptor retrogenic mice.

Freitag J, Heink S, Roth E, Wittmann J, Jäck HM, Kamradt T.

PLoS One. 2014 Oct 8;9(10):e109199. doi: 10.1371/journal.pone.0109199. eCollection 2014.

2.

IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.

Huber M, Heink S, Pagenstecher A, Reinhard K, Ritter J, Visekruna A, Guralnik A, Bollig N, Jeltsch K, Heinemann C, Wittmann E, Buch T, Prazeres da Costa O, Brüstle A, Brenner D, Mak TW, Mittrücker HW, Tackenberg B, Kamradt T, Lohoff M.

J Clin Invest. 2013 Jan;123(1):247-60. doi: 10.1172/JCI63681. Epub 2012 Dec 10.

3.

PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome.

Berod L, Heinemann C, Heink S, Escher A, Stadelmann C, Drube S, Wetzker R, Norgauer J, Kamradt T.

Eur J Immunol. 2011 Mar;41(3):833-44. doi: 10.1002/eji.201040504. Epub 2011 Feb 1.

4.

The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.

Drube S, Heink S, Walter S, Löhn T, Grusser M, Gerbaulet A, Berod L, Schons J, Dudeck A, Freitag J, Grotha S, Reich D, Rudeschko O, Norgauer J, Hartmann K, Roers A, Kamradt T.

Blood. 2010 May 13;115(19):3899-906. doi: 10.1182/blood-2009-10-247411. Epub 2010 Mar 3.

PMID:
20200353
5.

A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.

Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, Elflein K, Hünig T, Mittrücker HW, Brüstle A, Kamradt T, Lohoff M.

Eur J Immunol. 2009 Jul;39(7):1716-25. doi: 10.1002/eji.200939412.

6.

The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.

Brüstle A, Heink S, Huber M, Rosenplänter C, Stadelmann C, Yu P, Arpaia E, Mak TW, Kamradt T, Lohoff M.

Nat Immunol. 2007 Sep;8(9):958-66. Epub 2007 Aug 5.

PMID:
17676043

Supplemental Content

Loading ...
Support Center